-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is only for medical professionals to read and refer to clinical information.
1s Touch Daprucalopride is a new generation of highly selective, high-affinity serotonin 4 receptor agonist, which can stimulate intestinal smooth muscle contraction and peristalsis, and promote colon movement.
In order to achieve the purpose of accelerating defecation [1]
.
At present, studies have proved that prucalopride is safer and more effective in the treatment of chronic constipation.
However, due to the lack of high-quality research and the number of included literatures, the above conclusions should be treated with caution [2]
.
Recently, Am J Gastroenterol, the journal of the American Academy of Gastroenterology, published the results of a post-trial analysis that assessed the effect of pracarbapride on chronic patients with moderate to severe abdominal distension at baseline.
The impact of abdominal distension in patients with idiopathic constipation, let’s take a look at today’s news! References: [1] Zou Duowu, Ke Meiyun, Yuan Yaozong, et al.
A Chinese multi-center randomized, double-blind, placebo-controlled clinical study of prucalopride in the treatment of chronic constipation[J].
Chinese Journal of Digestion, 2012, 32 ( 12): 847-851[2] Hou Yi, Gu Yunfei, Zhu Bingyi.
A systematic review of the treatment of chronic constipation with prucalopride[J].
World Chinese Journal of Digestion,2014,22(04):588-595.
More frontiers Clinical information pays attention to clinical assistants in the medical community.
Source of this article: Clinical assistant editor in the medical community: Xiao Dangdang Sun Ying.
The medical community strives to be accurate and reliable when its published content is reviewed and approved, but it is not about the timeliness of the published content and the cited data Make any promises and guarantees for the accuracy and completeness of (if any), and assume no responsibility for the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
1s Touch Daprucalopride is a new generation of highly selective, high-affinity serotonin 4 receptor agonist, which can stimulate intestinal smooth muscle contraction and peristalsis, and promote colon movement.
In order to achieve the purpose of accelerating defecation [1]
.
At present, studies have proved that prucalopride is safer and more effective in the treatment of chronic constipation.
However, due to the lack of high-quality research and the number of included literatures, the above conclusions should be treated with caution [2]
.
Recently, Am J Gastroenterol, the journal of the American Academy of Gastroenterology, published the results of a post-trial analysis that assessed the effect of pracarbapride on chronic patients with moderate to severe abdominal distension at baseline.
The impact of abdominal distension in patients with idiopathic constipation, let’s take a look at today’s news! References: [1] Zou Duowu, Ke Meiyun, Yuan Yaozong, et al.
A Chinese multi-center randomized, double-blind, placebo-controlled clinical study of prucalopride in the treatment of chronic constipation[J].
Chinese Journal of Digestion, 2012, 32 ( 12): 847-851[2] Hou Yi, Gu Yunfei, Zhu Bingyi.
A systematic review of the treatment of chronic constipation with prucalopride[J].
World Chinese Journal of Digestion,2014,22(04):588-595.
More frontiers Clinical information pays attention to clinical assistants in the medical community.
Source of this article: Clinical assistant editor in the medical community: Xiao Dangdang Sun Ying.
The medical community strives to be accurate and reliable when its published content is reviewed and approved, but it is not about the timeliness of the published content and the cited data Make any promises and guarantees for the accuracy and completeness of (if any), and assume no responsibility for the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
